550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers
Popiel, D., Mikołajczyk, A., Skupinska, M.M., Hucz-Kalitowska, J., Stańczak, P., Piotrkowska, N., Yamani, A., Dubiel, K., Pieczykolan, J., Wieczorek, M., Stanczak, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1409P Comparing different methods of FGFR1 aberrations analysis in squamous cell lung cancer (SqCLC) targeted therapy
Skupinska, M.M., Obtulowicz, T., Moes-Sosnowska, J., Rozy, A., Szczepulska, E., Langfort, R., Wynimko, J. Chorostowska, Stanczak, A., Pieczykolan, J., Wieczorek, M., Popiel, D.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
The role of FGFR2 amplification and expression in patients with advanced or metastatic gastric cancer receiving fluoropyrimidine-based chemotherapy
Skupinska, M.M., Jesiotr, M., Chrom, P., Mroz, A., Cierniak, S., Winiarek, M., Wyrwicz, L.S., Pieczykolan, J., Wieczorek, M., Stanczak, A., Bodnar, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
46O Preliminary results from a phase IA trial of selective FGFR1-3 inhibitor CPL304110 in patients with FGFR-deregulated advanced solid malignancies
Lugowska, I., Stanczak, A., Roszkowski, K., Dziadziuszko, R., Duchnowska, R., Kubiatowski, T., Bodnar, L., Szczylik, C., Chorostowska Wynimko, J., Popiel, D., Skupinska, M.M., Judycka, A., Rudzki, P., Pieczykolan, J., Wieczorek, M.
Published in ESMO open (01.03.2023)
Published in ESMO open (01.03.2023)
Get full text
Journal Article